🇺🇸 ARALAST Alpha1-Proteinase Inhibitor in United States

ARALAST Alpha1-Proteinase Inhibitor (ARALAST Alpha1-Proteinase Inhibitor) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

ARALAST Alpha1-Proteinase Inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ARALAST Alpha1-Proteinase Inhibitor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ARALAST Alpha1-Proteinase Inhibitor in United States?

Baxalta now part of Shire is the originator. The local marketing authorisation holder may differ — check the official source linked above.